-
Analysis: COVID-19 Underscores Need to Boost Pharma Manufacturing in Emerging Markets
The scramble to produce vaccines and therapeutics and the challenges of getting these products to poorer countries underscores the growing importance of local pharma manufacturers for these emerging markets.
- Categories
- Coronavirus
-
How Decentralized Business Models Can Serve India’s Rural Communities During – and After – COVID-19
Centralizing business operations can improve efficiency, but it can also hinder a company's ability to innovate and tailor products for local markets. Mahesh Yagnaraman at Acumen shares how two companies used their decentralized models to quickly address COVID-19's challenges and adjust their offerings accordingly. He explores how these agile models can better identify the needs of their communities, no matter how remote, and reach them effectively.
- Categories
- Coronavirus, Entrepreneurship
-
Analysis: China’s Ambitious COVID-19 Vaccination Plan to Test Its Production Capability
China aims to vaccinate at least half a billion of its people against COVID-19 in four months, a challenge that will test the country’s formidable industrial might just as it accelerates efforts to help inoculate the rest of the world.
- Categories
- Coronavirus
- Region
- Asia Pacific
-
Addressing COVID-19 While Building Long-Term Capacity: Trends and Opportunities in Africa’s Growing Pharmaceutical Markets
The African pharmaceutical market’s estimated worth is between US $40 – $65 billion, but it remains largely untapped, with a heavy reliance on imports. According to Biodun Awosusi at Health Systems and Development Enterprise, the COVID-19 crisis shows the urgent need to unlock new partnerships and investments to accelerate the local production of medical supplies, medicines and vaccines, which could save lives and create jobs. He explores how Africa’s pharmaceutical sector is responding to the pandemic, and how it could be strengthened for the longer term.
- Categories
- Coronavirus, Health Care
-
India Is Set to Become a Vital COVID Vaccines Maker — Perhaps Second Only to the U.S.
India could become the world’s second largest Covid vaccine maker, and analysts say the country has the capacity to produce for both its own population and other developing countries.
- Categories
- Coronavirus
- Region
- Asia Pacific
-
General Motors Commits to Being Carbon Neutral by 2040
General Motors is the latest automaker to publicly commit to setting science based targets with the aim of becoming completely carbon neutral by 2040. GM GM +4.3% joins Volkswagen, Ford and others in pledging a move to carbon neutrality although the other automakers have announced a 2050 timeline.
- Categories
- Energy
-
Analysis: International Trade: Year in Review 2020
The Covid-19 pandemic profoundly disrupted global trade in 2020. However, it has also caused new paradigms to emerge, some of which point to potentially positive outcomes over the medium term.
- Categories
- Coronavirus, Entrepreneurship
-
How India’s Renewable Energy Sector Survived and Thrived in a Turbulent 2020
Record-low solar tariffs and flexible clean power auctions pushed India’s renewable energy growth in the midst of pandemic impacts. Now, it’s a question of pace.
- Categories
- Energy
- Region
- Asia Pacific
Parent Organization
